
    
      The aim of this study is to determine whether treatment of temporomandibular joint added to
      the control group treatment and drug therapy patient base is more effective than just using
      the control group treatment and drug therapy in patients with chronic migraine and
      temporomandibular disorders to reduce pain and improve the quality of life related to health
      of patients.
    
  